Chen Yan, Sang Yingying, Ballew Shoshana H, Tin Adrienne, Chang Alex R, Matsushita Kunihiro, Coresh Josef, Kalantar-Zadeh Kamyar, Molnar Miklos Z, Grams Morgan E
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Division of Nephrology, Geisinger Health System, Danville, PA.
Am J Kidney Dis. 2017 Aug;70(2):244-251. doi: 10.1053/j.ajkd.2017.01.044. Epub 2017 Mar 28.
Recent studies suggest that potassium levels may differ by race. The basis for these differences and whether associations between potassium levels and adverse outcomes differ by race are unknown.
Observational study.
SETTING & PARTICIPANTS: Associations between race and potassium level and the interaction of race and potassium level with outcomes were investigated in the Racial and Cardiovascular Risk Anomalies in Chronic Kidney Disease (RCAV) Study, a cohort of US veterans (N=2,662,462). Associations between African ancestry and potassium level were investigated in African Americans in the Atherosclerosis Risk in Communities (ARIC) Study (N=3,450).
Race (African American vs non-African American and percent African ancestry) for cross-sectional analysis; serum potassium level for longitudinal analysis.
Potassium level for cross-sectional analysis; mortality and end-stage renal disease for longitudinal analysis.
The RCAV cohort was 18% African American (N=470,985). Potassium levels on average were 0.162mmol/L lower in African Americans compared with non-African Americans, with differences persisting after adjustment for demographics, comorbid conditions, and potassium-altering medication use. In the ARIC Study, higher African ancestry was related to lower potassium levels (-0.027mmol/L per each 10% African ancestry). In both race groups, higher and lower potassium levels were associated with mortality. Compared to potassium level of 4.2mmol/L, mortality risk associated with lower potassium levels was lower in African Americans versus non-African Americans, whereas mortality risk associated with higher levels was slightly greater. Risk relationships between potassium and end-stage renal disease were weaker, with no difference by race.
No data for potassium intake.
African Americans had slightly lower serum potassium levels than non-African Americans. Consistent associations between potassium levels and percent African ancestry may suggest a genetic component to these differences. Higher and lower serum potassium levels were associated with mortality in both racial groups.
近期研究表明,血钾水平可能因种族而异。这些差异的基础以及血钾水平与不良结局之间的关联是否因种族不同而存在差异尚不清楚。
观察性研究。
在慢性肾脏病种族与心血管风险异常(RCAV)研究中,对美国退伍军人队列(N = 2,662,462)的种族与血钾水平之间的关联以及种族和血钾水平与结局的相互作用进行了研究。在社区动脉粥样硬化风险(ARIC)研究中的非裔美国人(N = 3,450)中,对非洲血统与血钾水平之间的关联进行了研究。
用于横断面分析的种族(非裔美国人与非非裔美国人以及非洲血统百分比);用于纵向分析的血清钾水平。
用于横断面分析的血钾水平;用于纵向分析的死亡率和终末期肾病。
RCAV队列中18%为非裔美国人(N = 470,985)。与非非裔美国人相比,非裔美国人的血钾水平平均低0.162mmol/L,在对人口统计学、合并症和使用改变血钾的药物进行调整后,差异仍然存在。在ARIC研究中,非洲血统比例越高,血钾水平越低(每增加10%非洲血统,血钾水平降低-0.027mmol/L)。在两个种族组中,血钾水平的升高和降低均与死亡率相关。与血钾水平为4.2mmol/L相比,非裔美国人血钾水平较低时的死亡风险低于非非裔美国人,而血钾水平较高时的死亡风险略高。血钾与终末期肾病之间的风险关系较弱,且种族间无差异。
无钾摄入量数据。
非裔美国人的血清钾水平略低于非非裔美国人。血钾水平与非洲血统百分比之间的一致关联可能表明这些差异存在遗传因素。两个种族组中,血钾水平的升高和降低均与死亡率相关。